Clozapine and Psychiatric decompensation - a phase IV clinical study of FDA data
Summary:
Psychiatric decompensation is reported as a side effect among people who take Clozapine (clozapine), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Abilify, and have Psychotic disorder.
The phase IV clinical study analyzes which people have Psychiatric decompensation when taking Clozapine. It is created by eHealthMe based on reports of 83,401 people who have side effects when taking Clozapine from the FDA, and is updated regularly.
What is Clozapine?
Clozapine has active ingredients of clozapine. It is often used in schizophrenia. eHealthMe is studying from 83,728 Clozapine users. Check the latest studies of Clozapine.
What is Psychiatric decompensation?
Psychiatric decompensation (worsening of symptoms to the state of a serious mental disorder) is found to be associated with 135 drugs and 224 conditions by eHealthMe. Check the latest studies of Psychiatric decompensation.
83,401 people reported to have side effects when taking Clozapine.
Among them, 267 people (0.32%) have Psychiatric decompensation.
Among these 267 people:
How long have people been on Clozapine when they have Psychiatric decompensation? *
What is the gender of people who have Psychiatric decompensation when taking Clozapine? *
What is the age of people who have Psychiatric decompensation when taking Clozapine? *
What are other drugs people take besides Clozapine? *
What are other side effects people have besides Psychiatric decompensation? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Clozapine and have Psychiatric decompensation?
- Check whether Psychiatric decompensation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Clozapine:
- Clozapine (83,728 reports)
Psychiatric decompensation treatments and more:
- Psychiatric decompensation (2,202 reports)
How severe was Psychiatric decompensation and when was it recovered:
Expand to all the drugs that have ingredients of clozapine:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Clozapine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Psychiatric decompensation:
- Psychiatric decompensation (135 drugs)
Browse all the conditions that are associated with Psychiatric decompensation:
- Psychiatric decompensation (224 conditions)
Related publications that referenced our studies
- Grover S, Sahoo S, "Clozapine induced akathisia: A case report and review of the evidence", Indian journal of pharmacology, 2015 Jan .
- Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
- Grover S, Sahoo S, "Clozapine induced akathisia: A case report and review of the evidence", Indian journal of pharmacology, 2015 Jan .
- Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on clozapine (the active ingredients of Clozapine) and Clozapine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Myalgia Aggravated in Apriso, how severe and when it was recovered? - 2 seconds ago
- Could Plaquenil cause Alanine Aminotransferase Increased? - 3 seconds ago
- Drug interactions of Movantik and Xolair - 4 seconds ago
- Could Alprazolam cause Retching? - 5 seconds ago
- Spironolactone and Cachexia for Men aged 60+ - 6 seconds ago
- Drug interactions of Duloxetine Hydrochloride and Entyvio - 6 seconds ago
- Allopurinol and Common Peroneal Nerve Dysfunction for Men aged 50-59 - 8 seconds ago
- Allopurinol and Peroneal Nerve Injury for Men aged 50-59 - 8 seconds ago
- Allopurinol and Neuropathy - Common Peroneal Nerve for Men aged 50-59 - 8 seconds ago
- Allopurinol and Peroneal Nerve Palsy for Men aged 50-59 - 9 seconds ago